Akèy › Obèsite › Texas › The Woodlands
Etid klinik pou Obèsite nan The Woodlands, TX
12 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote The Woodlands (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- Tcr Institute Llc, Kingwood · 20 mi lwen
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Ap rekriteFaz 2
- Texas Cardiology Associates of Houston, Kingwood · 20 mi lwen
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Ap rekriteFaz 3
- Martin Diagnostic Clinic, Tomball · 9 mi lwen
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Ap rekriteFaz 3
- Activian Clinical Research, Kingwood · 20 mi lwen
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ap rekriteFaz 3
- AURORA-2 Clinical Site, Tomball · 9 mi lwen
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Ap rekriteFaz 3
- Northwest Houston Clinical Research PLLC, Tomball · 9 mi lwen
- Javara Research, Conroe · 11 mi lwen
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 3
- AURORA-1 Clinical Site, Tomball · 9 mi lwen
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Ap rekriteFaz 3
- DM Clinical Research, Tomball · 9 mi lwen
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Tomball · 9 mi lwen
- Kailera Clinical Site, Kingwood · 20 mi lwen
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Tomball · 9 mi lwen
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Ap rekriteFaz 3
- Northwest Houston Heart Center, Tomball · 9 mi lwen
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Ap rekriteFaz 3
- Javara Inc. / Privia Medical Group Gulf Coast PLLC, Conroe · 11 mi lwen
Etid Obèsite nan lòt vil
- Houston, TX43 etid
- Chicago, IL41 etid
- New York City, NY40 etid
- San Antonio, TX40 etid
- Washington, DC33 etid
- Orlando, FL32 etid
- Dallas, TX30 etid
- Boston, MA28 etid
- Las Vegas, NV27 etid
- Miami, FL27 etid
- Baltimore, MD26 etid
- Jacksonville, FL25 etid
Lòt etid nan The Woodlands
- Kansè Poumon ki pa ti selil15 etid
- Sipwa10 etid
- Kansè nan tete10 etid
- Degeneresans makile9 etid
- Maladi kadyovaskilè9 etid
- Kansè Metastatik9 etid
- Dyabèt Tip 27 etid
- Ensifizyans kadyak7 etid
- Kansè poumon7 etid
- Ateroskleroz6 etid
- Atrofi Jeyografik6 etid
- Kansè pwostat6 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.